These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7747097)

  • 1. Serological and clinical characteristics of measles vaccine failure in Japan.
    Hidaka Y; Aoki T; Akeda H; Miyazaki C; Ueda K
    Scand J Infect Dis; 1994; 26(6):725-30. PubMed ID: 7747097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of secondary vaccine failures in measles outbreaks.
    Mathias RG; Meekison WG; Arcand TA; Schechter MT
    Am J Public Health; 1989 Apr; 79(4):475-8. PubMed ID: 2929807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of IgM tests for analysis of the causes of measles vaccine failures: experience gained in an epidemic in Hungary in 1980 and 1981.
    Nagy G; Kósa S; Takátsy S; Koller M
    J Med Virol; 1984; 13(1):93-103. PubMed ID: 6693863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of primary and secondary measles vaccine failures by measurement of immunoglobulin G avidity in measles cases during the 1997 São Paulo epidemic.
    Pannuti CS; Morello RJ; Moraes JC; Curti SP; Afonso AM; Camargo MC; Souza VA
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):119-22. PubMed ID: 14715557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles outbreak in Ibadan: clinical, serological and virological identification of affected children in selected hospitals.
    Adu FD; Ikusika A; Omotade O
    J Infect; 1997 Nov; 35(3):241-5. PubMed ID: 9459395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age.
    Paunio M; Hedman K; Davidkin I; Valle M; Heinonen OP; Leinikki P; Salmi A; Peltola H
    Epidemiol Infect; 2000 Apr; 124(2):263-71. PubMed ID: 10813152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-modified measles in previously immunized children in Accra, Ghana: clinical, virological and serological parameters.
    Ishiwada N; Addae MM; Tetteh JK; Yempewu SM; Ofori-Adjei D; Kamiya H; Akanmori BD
    Trop Med Int Health; 2001 Sep; 6(9):694-8. PubMed ID: 11555436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A measles outbreak from an index case with immunologically confirmed secondary vaccine failure.
    Kurata T; Kanbayashi D; Egawa K; Kinoshita M; Yoshida H; Miyazono M; Motomura K
    Vaccine; 2020 Feb; 38(6):1467-1475. PubMed ID: 31831219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case study of measles vaccination for university students during the measles outbreak in Tokyo, Japan, 2007.
    Fujisaki R; Yamamura M; Abe S; Shimogawara K; Kasahara M; Nishiya H; Makimura M; Makimura K
    J Infect Chemother; 2012 Jun; 18(3):341-6. PubMed ID: 22134852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles seroepidemiology among adolescents and young adults: response to revaccination.
    Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
    East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.
    Edmonson MB; Addiss DG; McPherson JT; Berg JL; Circo SR; Davis JP
    JAMA; 1990 May; 263(18):2467-71. PubMed ID: 2278542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early two-dose measles vaccination schedule in Guinea-Bissau: good protection and coverage in infancy.
    Garly ML; Martins CL; Balé C; da Costa F; Dias F; Whittle H; Aaby P
    Int J Epidemiol; 1999 Apr; 28(2):347-52. PubMed ID: 10342702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waning of vaccine-induced immunity: is it a problem in Africa?
    Aaby P; Cisse B; Simondon F; Samb B; Soumaré M; Whittle H
    Am J Epidemiol; 1999 Feb; 149(4):304-5. PubMed ID: 10025471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles vaccine: immunity, reinfection and revaccination.
    Linnemann CC
    Am J Epidemiol; 1973 Jun; 97(6):365-71. PubMed ID: 4713932
    [No Abstract]   [Full Text] [Related]  

  • 15. Outbreak of measles among persons with prior evidence of immunity, New York City, 2011.
    Rosen JB; Rota JS; Hickman CJ; Sowers SB; Mercader S; Rota PA; Bellini WJ; Huang AJ; Doll MK; Zucker JR; Zimmerman CM
    Clin Infect Dis; 2014 May; 58(9):1205-10. PubMed ID: 24585562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles immunity in children vaccinated before one year of age.
    Schluederberg A; Lamm SH; Landrigan PJ; Black FL
    Am J Epidemiol; 1973 Jun; 97(6):402-9. PubMed ID: 4713935
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing age-dependent susceptibility to measles in Japan.
    Kinoshita R; Nishiura H
    Vaccine; 2017 Jun; 35(25):3309-3317. PubMed ID: 28501456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of high-dose Edmonston-Zagreb measles vaccine in the Gambia: antibody response and side-effects.
    Whittle H; Hanlon P; O'Neill K; Hanlon L; Marsh V; Jupp E; Aaby P
    Lancet; 1988 Oct; 2(8615):811-4. PubMed ID: 2902264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The application of measles specific IgM and IgG antibody detection in classification measles vaccine failure, Tianjin].
    Ding YX; Mao NY; Zhang Y; Gao ZG; Xu WW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 May; 53(5):508-512. PubMed ID: 31091610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.